# Infinity Stock Financials

INFI | - USA Stock | ## USD 2.74 0.08 3.01% |

Understanding current and past Infinity Pharmaceuti Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Infinity Pharmaceuti's financial statements are interrelated, with each one affecting the others. For example, an increase in Infinity Pharmaceuti's assets may result in an increase in income on the income statement. Because of this, it is necessary to analyze all of Infinity Pharmaceuti's financials over time to get the whole picture.

Infinity Pharmaceuti Enterprise Value is most likely to decrease significantly in the upcoming years. The preceding year's Enterprise Value was reported at 119.15 Million. The current Invested Capital is estimated to increase to about 1.1 **M**, while Net Income Per Employee is projected to decrease to (1.9

**M**).

We strongly advise to harness analysis of Infinity Pharmaceuti fundamentals to see if markets are presently mispricing the company. We were able to analyze and collect data for thirty-four available reported financial drivers for Infinity Pharmaceuti, which can be compared to its competitors. To make sure the equity is not overpriced, please check out all Infinity Pharmaceuti financials, including its number of shares shorted, cash and equivalents, earnings per share, as well as the relationship between the revenue and current ratio . Please also validate Infinity Pharmaceuti price to book to confirm the company can sustain itself down the road. Use Infinity Pharmaceuti to enhance returns of your portfolios. The stock experiences an unexpected upward trend. Watch out for market signals. Check odds of Infinity Pharmaceuti to be traded at $3.29 in 90 days.

## Infinity Fundamentals | Infinity Select Account or Indicator |

With this module, you can analyze Infinity financials for your investing period. You should be able to track the changes in Infinity Pharmaceuti individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.

The fundamental analysis of Infinity Pharmaceuti is a critical element in measuring its lifeblood. The essential information of the day-to-day investment outlook for Infinity Pharmaceuti includes many different criteria found on its balance sheet. For example, investors should never minimize Infinity Pharmaceuti's ability to pay suppliers or employees on time, making sure interest payments are not accumulating or correctly timing where and how to re-invest extra cash. Any individual investor needs to monitor Infinity Pharmaceuti's cash flow, debt, and profitability to effectively and accurately make more informed decisions on whether to invest in Infinity Pharmaceuti.

### Infinity Pharmaceuti Cash

Chance Of Financial Distress

Less than 2

Infinity Pharmaceuti has

**less than 2 (%) percent**chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Infinity Pharmaceuti stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More InfoThe data published in Infinity Pharmaceuti's official financial statements usually reflect Infinity Pharmaceuti's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Infinity Pharmaceuti. For example, before you start analyzing numbers published by Infinity accountants, it's critical to develop an understanding of what Infinity Pharmaceuti's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.

Please note, the presentation of Infinity Pharmaceuti's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Infinity Pharmaceuti's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Infinity Pharmaceuti's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Infinity Pharmaceuti. Please utilize our Beneish M Score to check the likelihood of Infinity Pharmaceuti's management to manipulate its earnings.

## Infinity Pharmaceuti Company Summary

Infinity Pharmaceuti competes with Brickell Biotech, Mustang Bio, Bridgebio Pharma, Bioatla, and Biocardia. Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Infinity Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Cambridge, Massachusetts. Infinity Pharmaceuti operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 23 people.Specialization | Healthcare, Biotechnology |

Instrument | USA Stock View All |

Exchange | NASDAQ Exchange |

CIK Number | 0001113148 |

CUSIP | 254675101 |

Older Symbol | DPII |

Region | North America |

Location | Massachusetts; U.S.A |

Business Address | 1100 Massachusetts Avenue, |

Sector | Healthcare |

Industry | Biotechnology |

Benchmark | DOW |

Website | www.infi.com |

Phone | 617 453 1000 |

Currency | USD - US Dollar |

## Infinity Pharmaceuti Key Financial Ratios

Generally speaking, Infinity Pharmaceuti's financial ratios allow both analysts and investors to convert raw data from Infinity Pharmaceuti's financial statements into concise, actionable information that can be used to evaluate the performance of Infinity Pharmaceuti over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Infinity Pharmaceuti reports annually and quarterly.Return On Asset | (34.64) % | |||

Price to Earning | (1.63) X | |||

Price to Book | 4.50 X |

## Infinity Pharmaceuti Key Balance Sheet Accounts

2016 | 2017 | 2018 | 2019 | 2020 | 2021 (projected) | ||

Accounts Payable | 2.41 M | 459 K | 1.2 M | 1.62 M | 2.98 M | 3.74 M | |

Total Assets | 125.66 M | 59.35 M | 60.22 M | 49.01 M | 39.32 M | 40.35 M | |

Current Assets | 101.66 M | 58.39 M | 59.82 M | 44.58 M | 36.02 M | 36.97 M | |

Assets Non Current | 24 M | 967 K | 397 K | 4.43 M | 3.3 M | 3.39 M | |

Cash and Equivalents | 75.21 M | 34.61 M | 48.62 M | 22.26 M | 28.59 M | 29.35 M | |

Shareholders Equity | 82.45 M | 47.73 M | 52.46 M | 7.73 M | (22.99 M) | (23.59 M) | |

Investments | 18.53 M | 23 M | 9.97 M | 20.5 M | 5.68 M | 5.83 M | |

Investments Current | 18 M | 23 M | 9.97 M | 20.18 M | 5.51 M | 5.66 M | |

Total Liabilities | 43.2 M | 11.62 M | 7.76 M | 41.29 M | 62.31 M | 61.7 M | |

Current Liabilities | 23.86 M | 11.6 M | 7.72 M | 9.7 M | 11.05 M | 16.78 M |

## Infinity Pharmaceuti Key Income Statement Accounts

2016 | 2017 | 2018 | 2019 | 2020 | 2021 (projected) | ||

Consolidated Income | (30.1 M) | (41.83 M) | (11.25 M) | (47.06 M) | (40.49 M) | (43.69 M) | |

Gross Profit | 18.72 M | 6 M | 22.15 M | 3.05 M | 1.72 M | 1.76 M | |

Interest Expense | 1.23 M | 1.01 M | 93 K | 2.56 M | 2.44 M | 2.3 M | |

Net Income | (30.1 M) | (41.83 M) | (11.25 M) | (47.06 M) | (40.49 M) | (43.69 M) | |

Operating Expenses | 49.61 M | 42.45 M | 34.08 M | 48.71 M | 40.22 M | 63.4 M | |

Operating Income | (30.89 M) | (36.45 M) | (11.93 M) | (45.66 M) | (38.5 M) | (41.54 M) | |

Revenues | 18.72 M | 6 M | 22.15 M | 3.05 M | 1.72 M | 1.76 M |

## Infinity Pharmaceuti Key Cash Accounts

2016 | 2017 | 2018 | 2019 | 2020 | 2021 (projected) | ||

Capital Expenditure | (6.43 M) | 1.48 M | 707 K | (2.33 M) | (43 K) | (46.39 K) | |

Depreciation Amortization and Accretion | 3.42 M | 1.72 M | 191 K | 219 K | 483 K | 495.71 K | |

Net Cash Flow or Change in Cash and Cash Equivalents | (114.11 M) | (41.13 M) | 14.01 M | (26.04 M) | 6.33 M | 6.83 M | |

Issuance Purchase of Equity Shares | 332 K | 146 K | 9.62 M | 112 K | 7.87 M | 8.08 M | |

Net Cash Flow from Financing | (83 K) | (146 K) | 5.62 M | 27.73 M | 27.44 M | 30.4 M | |

Net Cash Flow from Investing | 40.33 M | (4.28 M) | 13.1 M | (12.24 M) | 14.63 M | 12.27 M | |

Net Cash Flow Investment Acquisitions and Disposals | 38.85 M | (4.99 M) | 13.1 M | (9.91 M) | 14.67 M | 13.06 M | |

Net Cash Flow from Operations | (154.36 M) | (36.71 M) | (4.71 M) | (41.53 M) | (35.74 M) | (38.56 M) | |

Share Based Compensation | 13.71 M | 6.97 M | 3.45 M | 2.13 M | 1.46 M | 1.49 M |

## Infinity Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Infinity Pharmaceuti's current stock value. Our valuation model uses many indicators to compare Infinity Pharmaceuti value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Infinity Pharmaceuti competition to find correlations between indicators driving Infinity Pharmaceuti's intrinsic value. More Info.Infinity Pharmaceuti is rated**third**overall in market capitalization category among related companies. It is rated

**below average**in return on equity category among related companies . . Infinity Pharmaceuti Market Capitalization is most likely to decrease significantly in the upcoming years. The last year's value of Market Capitalization was reported at 136.12 Million

## Infinity Pharmaceuti Systematic Risk

Infinity Pharmaceuti's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Infinity Pharmaceuti volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.

The output start index for this execution was sixty with a total number of output elements of one. The Beta measures systematic risk based on how returns on Infinity Pharmaceuti correlated with the market. If Beta is less than 0 Infinity Pharmaceuti generally moves in the opposite direction as compared to the market. If Infinity Pharmaceuti Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Infinity Pharmaceuti is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Infinity Pharmaceuti is generally in the same direction as the market. If Beta > 1 Infinity Pharmaceuti moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

## About Infinity Pharmaceuti Financials

What exactly are Infinity Pharmaceuti Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Infinity Pharmaceuti's income statement, its balance sheet, and the statement of cash flows. Potential Infinity Pharmaceuti investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Infinity Pharmaceuti investors may use each financial statement separately, they are all related. The changes in Infinity Pharmaceuti's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Infinity Pharmaceuti's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

2020 | 2021 (projected) | |

Accounts Payable | 2.98 M | 3.74 M |

Receivables | 1.07 M | 856.73 K |

## Infinity Pharmaceuti October 21, 2021 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Infinity Pharmaceuti help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Infinity Pharmaceuti. We use our internally-developed statistical techniques to arrive at the intrinsic value of Infinity Pharmaceuti based on widely used predictive technical indicators. In general, we focus on analyzing Infinity Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Infinity Pharmaceuti's daily price indicators and compare them against related drivers.

Downside Deviation | 7.22 | |||

Information Ratio | 0.0423 | |||

Maximum Drawdown | 71.4 | |||

Value At Risk | (9.09) | |||

Potential Upside | 7.47 |

Please see Risk vs Return Analysis. Note that the Infinity Pharmaceuti information on this page should be used as a complementary analysis to other Infinity Pharmaceuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Money Managers module to screen money managers from public funds and ETFs managed around the world.

## Complementary Tools for Infinity Stock analysis

When running Infinity Pharmaceuti price analysis, check to measure Infinity Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuti is operating at the current time. Most of Infinity Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Infinity Pharmaceuti's price. Additionally, you may evaluate how the addition of Infinity Pharmaceuti to your portfolios can decrease your overall portfolio volatility.

Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | Go | |

Stock ScreenerFind equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | Go | |

Insider ScreenerFind insiders across different sectors to evaluate their impact on performance | Go | |

Volatility AnalysisGet historical volatility and risk analysis based on latest market data | Go | |

Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | Go |

The market value of Infinity Pharmaceuti is measured differently than its book value, which is the value of Infinity that is recorded on the company's balance sheet. Investors also form their own opinion of Infinity Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Infinity Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Infinity Pharmaceuti's market value can be influenced by many factors that don't directly affect Infinity Pharmaceuti underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Infinity Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Infinity Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infinity Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.